Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Lyophilized Human Rabies Vaccine (Human Diploid Cell) Using Different Schedules
NCT07500207Phase 3Enrolling by invitation
- Sponsor
- Changchun BCHT Biotechnology Co.
- Start
- Mar 2026
- Primary completion
- May 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies vaccine in rabies, sponsored by Changchun BCHT Biotechnology Co.. Started Mar 2026; status: enrolling by invitation.
02
Drugs
rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07500207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07500207.